126 related articles for article (PubMed ID: 8080676)
1. Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients.
Bacci G; Picci P; Ferrari S; Sangiorgi L; Zanone A; Brach del Prever A
Eur J Cancer; 1994; 30A(5):620-6. PubMed ID: 8080676
[TBL] [Abstract][Full Text] [Related]
2. Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies.
Bacci G; Picci P; Ferrari S; Casadei R; Brach Del Prever A; Tienghi A; Mancini A
J Chemother; 1993 Aug; 5(4):237-46. PubMed ID: 8229152
[TBL] [Abstract][Full Text] [Related]
3. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
Bacci G; Picci P; Pignatti G; De Cristofaro R; Dallari D; Avella M; Manfrini M; Marangolo M; Ferruzzi A; Mercuri M
Clin Orthop Relat Res; 1991 Sep; (270):87-98. PubMed ID: 1884564
[TBL] [Abstract][Full Text] [Related]
5. The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively.
Bacci G; Picci P; Avella M; Dallari D; Ferrari S; Prasad R; Di Scioscio M; Malaguti C; Caldora P
J Chemother; 1990 Apr; 2(2):127-35. PubMed ID: 2362188
[TBL] [Abstract][Full Text] [Related]
6. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
7. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
8. Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy.
Pignatti G; Bacci G; Picci P; Dallari D; Bertoni F; Bacchini P; Capanna R
Clin Orthop Relat Res; 1991 Sep; (270):99-106. PubMed ID: 1884565
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.
Bacci G; Briccoli A; Ferrari S; Longhi A; Mercuri M; Capanna R; Donati D; Lari S; Forni C; DePaolis M
Eur J Cancer; 2001 Nov; 37(16):2030-9. PubMed ID: 11597381
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
11. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
12. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M
J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study.
Bacci G; Ruggieri P; Picci P; Mercuri M; Ferraro A; Tella G; Ferrari S; Bertoni F; Comandone A
J Chemother; 1996 Feb; 8(1):70-81. PubMed ID: 8835114
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Bacci G; Ferrari S; Bertoni F; Ruggieri P; Picci P; Longhi A; Casadei R; Fabbri N; Forni C; Versari M; Campanacci M
J Clin Oncol; 2000 Dec; 18(24):4016-27. PubMed ID: 11118462
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study.
Bacci G; Ferrari S; Mercuri M; Longhi A; Capanna R; Tienghi A; Brach del Prever A; Comandone A; Cesari M; Bernini G; Picci P
Acta Oncol; 1998; 37(1):41-8. PubMed ID: 9572653
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant form.
Avella M; Bacci G; McDonald DJ; Di Scioscio M; Picci P; Campanacci M
Chemioterapia; 1988 Apr; 7(2):133-7. PubMed ID: 3165057
[TBL] [Abstract][Full Text] [Related]
18. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for telangiectatic osteogenic sarcoma of the extremities.
Bacci G; Pignatti G; Dallari D; Mercuri M; Bertoni F; Bacchini P; Fontana M; Avella M; Campanacci M
J Chemother; 1989 Jun; 1(3):190-6. PubMed ID: 2477510
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
20. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
